Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

NCT07661056 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Graves Disease

Interventions

DRUG: BHV-1300
DRUG: Placebo

Sponsor

Biohaven Therapeutics Ltd.